New skincare offers hope for users of Ozempic and Mounjaro

Rapid weight loss from injectables raises concerns among women regarding skin elasticity.

Women seek solutions for saggy skin from weight loss treatments

In the UK, around one in ten women are using weight-loss injections like Ozempic. These drugs lead to rapid fat loss, especially in the face, resulting in what has been termed ‘Ozempic face’. Symptoms include hollowed cheeks and increased wrinkles, which are significant concerns for the predominantly older demographic using these treatments. Skincare brands have rushed to introduce products aimed at counteracting these changes. Among them is Image Skincare Vol.U.Lift, designed to combat the effects of significant weight loss with ingredients intended to enhance skin volume and hydration. Other notable products include the SkinCeuticals A.G.E. Interrupter Ultra Serum and ROC Derm Correxion Firming Serum Stick, which offer various approaches to address sagging facial skin. Despite innovative formulations, experts caution that no topical treatment can fully restore lost volume or the structure of the face.

The rise of injectables like Ozempic has put a spotlight on the cosmetic effects of weight loss on mature skin. As consumers increasingly turn to these drugs, the demand for effective skincare solutions is likely to grow. Companies are introducing products that promise to tackle the unique challenges of 'Ozempic face', but the critical question is whether they can deliver real, long-term results. While initial findings may show improvements, the underlying aging processes and loss of fat pads cannot be entirely reversed by creams alone. This highlights a tension in consumer expectations versus the capabilities of skincare innovations in the market.

Highlights

As the beauty industry evolves, the interplay between weight loss and skincare will remain a critical topic.